Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release
- 1 February 2004
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 4 (2) , 223-234
- https://doi.org/10.1016/j.intimp.2003.12.006
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Lipopolysaccharide Rapidly Traffics to and from the Golgi Apparatus with the Toll-like Receptor 4-MD-2-CD14 Complex in a Process That Is Distinct from the Initiation of Signal TransductionJournal of Biological Chemistry, 2002
- IRAK-M Is a Negative Regulator of Toll-like Receptor SignalingCell, 2002
- Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-κB, ERK and p38 MAPK signal pathwaysImmunology Letters, 2002
- Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-α production through activation of NF-κBInternational Immunology, 2001
- RETRACTED: DNA-PKcs Is Required for Activation of Innate Immunity by Immunostimulatory DNACell, 2000
- Antisense IRAK-1 oligonucleotide blocks activation of NF-κB and AP-1 induced by IL-18Immunopharmacology, 2000
- Immunostimulatory DNA: Sequence‐dependent production of potentially harmful or useful cytokinesEuropean Journal of Immunology, 1997
- Transcription factors AP-1 and NF-κB: Where steroids meet the gold standard of anti-rheumatic drugsInflammation Research, 1997
- Bacterial DNA causes septic shockNature, 1997
- Binding of chloroquine to DNAMolecular and Biochemical Parasitology, 1989